Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Unknown 4Completed 3Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 8Genitourinary 7Lymphoid 6Endocrine 6NET 5Breast 5Tumor-Agnostic 3Thoracic 3Head & Neck 3CNS 3Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Classical hematology 1

Conditions

Neoplasms 3

Interventions

Paclitaxel 57Gemcitabine 51Carboplatin 51Surveys and Questionnaires 48Docetaxel 37Bevacizumab 37pembrolizumab 33Nivolumab 29Cisplatin 28Fluorouracil 24Capecitabine 23Irinotecan 22Erlotinib Hydrochloride 22Sorafenib 20Leucovorin 19Afatinib 19Radiotherapy 18Pemetrexed 18Oxaliplatin 17Trastuzumab 16Ipilimumab 15regorafenib 14Blood Specimen Collection 14130-nm albumin-bound paclitaxel 14olaparib 13Interviews as Topic 13Cetuximab 13Albumin-Bound Paclitaxel 13atezolizumab 12Sunitinib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Positron Emission Tomography Computed Tomography × Tumor-Agnostic × Clear all
NCT06206642 2024-01-16

Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection

Lanzhou University Second Hospital

Phase NA Completed
92 enrolled
Tumor-Agnostic

Neoplasms

NCT04538950 2023-09-13

PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy

Mayo Clinic

Phase 1/2 Completed
6 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT02876731 2016-08-24

IMMETAOS

Institut Jean-Godinot

Phase NA Completed
13 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡